NCT03829800
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +5 more
- Locations
-
Not specified
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,008 public trials
712 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT03484689
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- Pok Oi Hopsital Hong Kong
NCT01819129
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Glendale, Arizona, United States
- Novo Nordisk Investigational Site Glendale, Arizona, United States
- Novo Nordisk Investigational Site Mesa, Arizona, United States
- Novo Nordisk Investigational Site Phoenix, Arizona, United States
NCT03050619
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Boehringer Ingelheim Investigational Site Ingelheim, Germany
Completed
An Observational Study to Evaluate Cardiovascular Outcomes of T2DM PatientsTreated With Gemigliptin
NCT02290301
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Pusan National University Hospital Busan, South Korea
NCT01870297
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chula Vista, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Orange, California, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cincinnati, Ohio, United States
NCT02002975
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
Not specified
NCT02790892
- Conditions
- Autoimmune Diseases, Coping Behavior, Diabetes Mellitus, +8 more
- Locations
-
- University of Manitoba Winnipeg, Manitoba, Canada
NCT02224417
- Conditions
- Behavior, Diabetes Mellitus, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- SingHealth Polyclinics (Geylang) Singapore
- SingHealth Polyclinic (Bedok) Singapore
NCT01512797
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- New York Obesity Nutrition Research Center, Columbia University New York, United States